Sun Pharmaceutical Industries announced a collaboration with US-based Pharmazz Inc to commercialize a medication used to treat cerebral ischemic stroke in India. One of the business's wholly-owned subsidiaries has entered into a license deal with...
LifeSphere Safety has been selected by medac, a German-based pharmaceutical manufacturer specializing in oncology and hematology, urology, and autoimmune diseases, to modernize its drug safety processes, according to ArisGlobal, a market leader...
The Cabinet Committee on Economic Affairs has approved foreign investment in Suven Pharmaceuticals by Cyprus-based Berhyanda Limited up to Rs 9,589 crore. Berhyanda has been granted permission by the Cabinet to acquire up to 76.1 percent of the...
The pharmacy automation devices market will grow from USD 5.72 Billion in 2022 to USD 11.60 Billion by 2032. The pharmacy automation devices market is witnessing a rise in demand due to the increasing requirement for automated dispensers and...
After showing a benefit in patients with advanced disease, Daiichi Sankyo Co. expects to file for US approval of its innovative lung cancer treatment by the end of March. Patients with non-small cell lung cancer who had progressed despite...
Adjuvant technology can improve vaccination effectiveness by activating the immune system, resulting in a stronger immune response.
Salipro Biotech and Sumitomo Pharma have formed a research partnership to better understand the pharmacological properties of a molecule from Sumitomo's drug discovery program. Both firms hope to improve Sumitomo's drug development program by...
The Global Antibiotic Research and Development Partnership (GARDP) and India-based Orchid Pharma Ltd (Orchid) have agreed to manufacture cefiderocol, an antibiotic used to treat certain Gram-negative infections. This agreement is a vital milestone...
NovaBay Pharmaceuticals, Inc. and BioStem Technologies, Inc. have announced an agreement under which NovaBay has been awarded the exclusive right to commercialize BioStem Technologies' Amniotic Tissue Allograft, which is designed to be used as a...
Sandoz, a major producer in generic and biosimilar pharmaceuticals, has signed a development and commercialization cooperation with Samsung Bioepis. According to the company's statement, the deal grants Sandoz exclusive rights to commercialize the...
, CDSCO.jpg)
